Association of Life's Essential 8 with metabolic dysfunction-associated steatotic liver disease (MASLD), a cross-sectional study from the NHANES 2003-2018

被引:2
|
作者
Liu, Xiangliang [1 ]
Chang, Yu [1 ]
Jia, Feng [1 ]
Li, Yuguang [1 ]
Wang, Yao [1 ]
Cui, Jiuwei [1 ]
机构
[1] First Hosp Jilin Univ, 1 Xinmin St, Changchun, Peoples R China
来源
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
关键词
Life's Essential 8 (LE8); Metabolic dysfunction-associated steatotic liver disease (MASLD); Cardiovascular Health (CVH); Weighted quantile sum regression (WQS) model; Restrictive cubic spline (RCS); NHANES; AMERICAN HEART ASSOCIATIONS; CARDIOVASCULAR-DISEASE; MEDITERRANEAN DIET; HEALTH; PREVALENCE; INDEX; COST; RISK;
D O I
10.1038/s41598-024-67728-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
There is limited research on the relationship between Life's Essential 8 (LE8) score and metabolic dysfunction-associated steatotic liver disease (MASLD). Our aim is to investigate the relationship between overall lifestyle assessed by LE-8 score and MASLD in a nationally representative sample. We employed the LE8 score to comprehensively evaluate cardiovascular health, the assessment of MASLD primarily utilized the Fatty Liver Index. The weighted logistic regression models, restrictive cubic splines (RCS), subgroup analyses and the weighted quantile sum (WQS) regression were used to evaluate the relationship between the cardiovascular health and MASLD. Logistic regression models revealed that higher LE8 scores were associated with lower odds of having MASLD. The RCS revealed a significant nonlinear dose-response relationship between LE8 scores and MASLD. The WQS regression model indicated that blood glucose contributed the most to the risk of MASLD. The subgroup analysis indicates that there are significant differences in this association across age, educational level, and poverty income ratio. Our study suggests that an inverse correlation between LE8 and the risk of MASLD. Our findings underscore the utility of the LE8 algorithm in MASLD risk assessment and provide support for MASLD prevention through the promotion of healthy lifestyles.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Association Between 'Life's Essential 8' and Periodontitis: A Cross-Sectional Study From the NHANES Database
    Lu, Shouyi
    Gao, Guoning
    INTERNATIONAL DENTAL JOURNAL, 2024, 74 (05) : 960 - 967
  • [42] Converging Pathways between Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Diabetes in Children
    Faienza, Maria Felicia
    Farella, Ilaria
    Khalil, Mohamad
    Portincasa, Piero
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (18)
  • [43] Evaluation of metabolic dysfunction-associated steatotic liver disease (MASLD) terminology in different clinical settings
    Iruzubieta, Paula
    Santos-Laso, Alvaro
    Arias-Loste, Maria Teresa
    Calleja, Jose Luis
    Crespo, Javier
    JOURNAL OF HEPATOLOGY, 2024, 80 (03) : e121 - e123
  • [44] Epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease (ALD)
    Wong, Robert J.
    METABOLISM AND TARGET ORGAN DAMAGE, 2024, 4 (04):
  • [45] Cutting edge: ferroptosis in metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis and therapy
    El-Sehrawy, Amr Ali Mohamed Abdelgawwad
    Rashid, Teeba Ammar
    Ullah, Muhammad Ikram
    Uthirapathy, Subasini
    Ganesan, Subbulakshmi
    Singh, Abhayveer
    Devi, Anita
    Joshi, Kamal Kant
    Jasim, Ahmed Salman
    Kadhim, Abed J.
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2025, 25 (01)
  • [46] Standardized evaluation of diabetic retinopathy using artificial intelligence and its association with metabolic dysfunction-associated steatotic liver disease in Japan: A cross-sectional study
    Komatsu, Koji
    Sano, Kei
    Fukai, Kota
    Nakagawa, Ryo
    Nakagawa, Takashi
    Tatemichi, Masayuki
    Nakano, Tadashi
    PLOS ONE, 2024, 19 (12):
  • [47] METALD, THE NEW CATEGORY OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) - HOW COMMON IS IT?
    Scheetz, Kate
    Kalagara, Sanah
    Vilar-Gomez, Eduardo
    Chalasani, Naga P.
    Vuppalanchi, Raj
    GASTROENTEROLOGY, 2024, 166 (05) : S477 - S478
  • [48] Novel insights of phenylalanine in Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) and cardiovascular complications
    Liu, J.
    Chen, Y.
    Qian, J.
    Cui, R.
    Demirkan, A.
    Zheng, Y.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [49] Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Shin, Soyeon
    Kim, Jaeyoung
    Lee, Ju Yeon
    Kim, Jun
    Oh, Chang-Myung
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2023, 32 (04) : 289 - 302
  • [50] Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance
    Hutchison, Alan L.
    Tavaglione, Federica
    Romeo, Stefano
    Charlton, Michael
    JOURNAL OF HEPATOLOGY, 2023, 79 (06) : 1524 - 1541